Stay updated on Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial

Sign up to get notified when there's something new on the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T21:37:52.000Z thumbnail image
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    8 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study record related to the safety and clinical activity of the combination of nivolumab and cabiralizumab for resectable biliary tract cancers.
    Difference
    0.2%
    Check dated 2024-06-06T14:33:01.000Z thumbnail image
  7. Check
    22 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to provide a detailed description of eligibility criteria, including examples such as a person's general health condition or prior treatments. This change offers more specific information about the criteria researchers use to select participants for the study.
    Difference
    26%
    Check dated 2024-05-22T21:14:29.000Z thumbnail image
  8. Check
    44 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:26:34.000Z thumbnail image

Stay in the know with updates to Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page.